• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Switch to mania after ayahuasca consumption in a man with bipolar disorder: a case report.双相障碍患者使用致幻剂依卡叶碱后转为躁狂:病例报告。
Int J Bipolar Disord. 2015 Feb 24;3:4. doi: 10.1186/s40345-014-0020-y. eCollection 2015.
2
[Clinical particularism of bipolar disorder: unipolar mania. About a patient's study in Tunesia].[双相情感障碍的临床特殊性:单相躁狂。关于突尼斯一名患者的研究]
Encephale. 2008 Sep;34(4):337-42. doi: 10.1016/j.encep.2007.06.008. Epub 2007 Oct 26.
3
Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).与抗抑郁药使用相关的躁狂/轻躁狂转换的自我报告病史:来自双相情感障碍系统治疗强化项目(STEP - BD)的数据。
J Clin Psychiatry. 2007 Oct;68(10):1472-9. doi: 10.4088/jcp.v68n1002.
4
Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder.双相情感障碍中抗抑郁药诱发的躁狂和轻躁狂的遗传特征。
Psychopharmacology (Berl). 2004 Aug;174(4):504-11. doi: 10.1007/s00213-004-1948-x. Epub 2004 Jul 10.
5
ECNP consensus meeting. Bipolar depression. Nice, March 2007.欧洲神经精神药理学会共识会议。双相抑郁症。英国尼斯,2007年3月。
Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23.
6
Antidepressant-associated switches from depression to mania in severe bipolar disorder.重度双相情感障碍中抗抑郁药引发的从抑郁到躁狂的转变
Bipolar Disord. 2007 Dec;9(8):851-9. doi: 10.1111/j.1399-5618.2007.00424.x.
7
Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.阿亚瓦斯卡、二甲基色胺与精神病:对人体研究的系统评价
Ther Adv Psychopharmacol. 2017 Apr;7(4):141-157. doi: 10.1177/2045125316689030. Epub 2017 Feb 23.
8
Mania induced by opipramol.奥匹哌醇所致躁狂
Indian J Psychol Med. 2015 Jan-Mar;37(1):96-8. doi: 10.4103/0253-7176.150852.
9
Adding Increased Energy or Activity to Criterion (A) of the DSM-5 Definition of Hypomania and Mania: Effect on the Diagnoses of 907 Patients From the Bipolar Collaborative Network.增加 DSM-5 轻躁狂和躁狂定义中标准(A)的能量或活动:对双相情感障碍协作网络 907 名患者诊断的影响。
J Clin Psychiatry. 2019 Oct 29;80(6):19m12834. doi: 10.4088/JCP.19m12834.
10
Cognitive deficits in bipolar disorders: Implications for emotion.双相情感障碍中的认知缺陷:对情绪的影响。
Clin Psychol Rev. 2018 Feb;59:126-136. doi: 10.1016/j.cpr.2017.11.006. Epub 2017 Nov 21.

引用本文的文献

1
Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity Analysis: A Systematic Thematic Review.迷幻药和二甲色胺不良事件和毒性分析:系统主题回顾。
Int J Toxicol. 2024 May-Jun;43(3):327-339. doi: 10.1177/10915818241230916. Epub 2024 Feb 16.
2
Manic episode following psilocybin use in a man with bipolar II disorder: a case report.一名双相II型障碍男性使用裸盖菇素后出现躁狂发作:病例报告
Front Psychiatry. 2023 Sep 22;14:1221131. doi: 10.3389/fpsyt.2023.1221131. eCollection 2023.
3
"A sense of the bigger picture:" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.“大局观”:对自我报告使用裸盖菇素的双相情感障碍患者进行随访访谈的定性分析。
PLoS One. 2022 Dec 14;17(12):e0279073. doi: 10.1371/journal.pone.0279073. eCollection 2022.
4
Psychedelics in the treatment of unipolar and bipolar depression.致幻剂在单相和双相抑郁症治疗中的应用
Int J Bipolar Disord. 2022 Jul 5;10(1):18. doi: 10.1186/s40345-022-00265-5.
5
Ayahuasca as a Decoction Applied to Human: Analytical Methods, Pharmacology and Potential Toxic Effects.用于人类的煎剂形式的死藤水:分析方法、药理学及潜在毒性作用
J Clin Med. 2022 Feb 21;11(4):1147. doi: 10.3390/jcm11041147.
6
N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.N,N-二甲基色胺与亚马孙地区的苦艾草植物药。
Hum Psychopharmacol. 2022 May;37(3):e2835. doi: 10.1002/hup.2835. Epub 2022 Feb 17.
7
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.迷幻疗法的跨诊断效应:基于研究领域标准(RDoC)的视角
Front Psychiatry. 2021 Dec 17;12:800072. doi: 10.3389/fpsyt.2021.800072. eCollection 2021.
8
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.迷幻知觉:心理健康服务使用者对裸盖菇素治疗的态度。
Ir J Med Sci. 2022 Jun;191(3):1385-1397. doi: 10.1007/s11845-021-02668-2. Epub 2021 Jun 15.
9
Ayahuasca: Uses, Phytochemical and Biological Activities.阿亚瓦斯卡:用途、植物化学与生物活性。
Nat Prod Bioprospect. 2019 Aug;9(4):251-265. doi: 10.1007/s13659-019-0210-5. Epub 2019 May 27.
10
[Ayahuasca-induced psychosis in a patient with bipolar disorder].[双相情感障碍患者服用死藤水引发的精神病]
Nervenarzt. 2019 Nov;90(11):1154-1155. doi: 10.1007/s00115-019-0728-0.

本文引用的文献

1
Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.口服安非他命和 harmala 生物碱后 N,N-二甲基色胺的代谢和处置。
Drug Test Anal. 2012 Jul-Aug;4(7-8):610-6. doi: 10.1002/dta.1344. Epub 2012 Apr 19.
2
beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO).骆驼蓬中的β-咔啉生物碱及其对人单胺氧化酶(MAO)的抑制作用。
Food Chem Toxicol. 2010 Mar;48(3):839-45. doi: 10.1016/j.fct.2009.12.019. Epub 2009 Dec 28.
3
Mania associated with antidepressant treatment: comprehensive meta-analytic review.抗抑郁药治疗相关的躁狂:全面的荟萃分析综述。
Acta Psychiatr Scand. 2010 Jun;121(6):404-14. doi: 10.1111/j.1600-0447.2009.01514.x. Epub 2009 Dec 2.
4
A case of beta-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract.一例因摄入骆驼蓬籽提取物导致的β-咔啉生物碱中毒病例。
Forensic Sci Int. 2008 Aug 6;179(2-3):e37-43. doi: 10.1016/j.forsciint.2008.05.003. Epub 2008 Jul 7.
5
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications.精神疾病中的氧化应激:证据基础与治疗意义。
Int J Neuropsychopharmacol. 2008 Sep;11(6):851-76. doi: 10.1017/S1461145707008401. Epub 2008 Jan 21.
6
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids.口服二甲基色胺(DMT)和哈尔满生物碱仪式性使用的风险评估。
Addiction. 2007 Jan;102(1):24-34. doi: 10.1111/j.1360-0443.2006.01652.x.
7
Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis.卡皮藤和绿玉叶金花的植物化学分析。
J Psychoactive Drugs. 2005 Jun;37(2):145-50. doi: 10.1080/02791072.2005.10399795.
8
Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.死藤水治疗潜力的临床研究:基本原理与监管挑战。
Pharmacol Ther. 2004 May;102(2):111-29. doi: 10.1016/j.pharmthera.2004.03.002.
9
Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.死藤水的人体药理学:主观及心血管效应、单胺代谢产物排泄及药代动力学。
J Pharmacol Exp Ther. 2003 Jul;306(1):73-83. doi: 10.1124/jpet.103.049882. Epub 2003 Mar 26.
10
Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors.β-咔啉及相关药物与5-羟色胺(5-HT₂和5-HT₁A)、多巴胺(D₂)及苯二氮䓬受体的结合
Drug Alcohol Depend. 2000 Aug 1;60(2):121-32. doi: 10.1016/s0376-8716(99)00148-9.

双相障碍患者使用致幻剂依卡叶碱后转为躁狂:病例报告。

Switch to mania after ayahuasca consumption in a man with bipolar disorder: a case report.

机构信息

Hospital de Emergencias Psiquiatricas Torcuato de Alvear, Av Warnes 2630, Capital Federal, Argentina ; Bipolar Disorder Program, Neurosciences Institute, Favaloro University, Buenos Aires, Argentina.

Hospital de Emergencias Psiquiatricas Torcuato de Alvear, Av Warnes 2630, Capital Federal, Argentina.

出版信息

Int J Bipolar Disord. 2015 Feb 24;3:4. doi: 10.1186/s40345-014-0020-y. eCollection 2015.

DOI:10.1186/s40345-014-0020-y
PMID:25713771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4338113/
Abstract

BACKGROUND

There is an increasing use of ayahuasca for recreational purposes. Furthermore, there is a growing evidence for the antidepressant properties of its components. However, there are no reports on the effects of this substance in the psychiatric setting. Harmaline, one of the main components of ayahuasca, is a selective and reversible MAO-A inhibitor and a serotonin reuptake inhibitor.

CASE REPORT

We present the case of a man with bipolar disorder who had a manic episode after an ayahuasca consumption ritual. This patient had had at least one hypomanic episode in the past and is currently depressed. We discuss the diagnostic repercussion of this manic episode.

CONCLUSION

There is lack of specificity in the diagnosis of substance-induced mental disorder. The knowledge of the pharmacodynamic properties of ayahuasca consumption allows a more physiopathological approach to the diagnosis of the patient.

摘要

背景

越来越多的人出于娱乐目的而使用死藤水。此外,其成分具有抗抑郁作用的证据也越来越多。然而,在精神科环境中,尚无关于这种物质的影响的报告。哈他胺是死藤水的主要成分之一,是一种选择性和可逆的 MAO-A 抑制剂和 5-羟色胺再摄取抑制剂。

病例报告

我们介绍了一位患有双相情感障碍的男性,在进行死藤水摄入仪式后出现躁狂发作。该患者过去至少有过一次轻躁狂发作,目前处于抑郁状态。我们讨论了此次躁狂发作的诊断影响。

结论

物质引起的精神障碍的诊断缺乏特异性。对死藤水摄入的药效学特性的了解,使得对患者的诊断可以采用更具生理病理特性的方法。